Media Advisory

Wednesday, April 25, 2007

NIDA Experts to Discuss Latest Science on Stimulant Abuse at ASAM Annual Scientific Meeting Addiction Specialists to Learn About Newest Treatments in Development

What: Treatment of Stimulant Dependence: The State of the Science

The National institute on Drug Abuse (NIDA), part of the National Institutes of Health, will present a full day symposium on the epidemiology of stimulant abuse and treatment as part of the 38th Annual Medical-Scientific Conference of the American Society of Addiction Medicine (ASAM). Led by NIDA Deputy Director Dr. Timothy P. Condon, NIDA experts will discuss the behavioral approaches that are currently the mainstay of treatment, the most recent studies involving contingency management techniques, and pharmacotherapeutic studies of marketed medications for the management of cocaine and methamphetamine dependence.

Why: Abuse of stimulants continues to be a major public health problem in the United States.
Neuroscience is uncovering new directions for medical therapies.

When: Friday, April 27, 2007: Dr. Condon at Plenary (9:00 a.m.)
Saturday April 28, 2007
10:00 a.m. – 12 Noon
2:00 – 4:00 p.m. Where: Marriott Doral Resort and Spa
Miami, Florida

Who: Featured Speakers from NIDA:
Dr. Timothy P. Condon, Deputy Director, NIDA
Dr. Frank Vocci, Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse (DPMCDA)
Dr. Ahmed Elkashef, Chief of the Clinical Medical Branch, DPMCDA
Dr. Wilson Compton, Director, Division of Epidemiology, Services and Prevention Research (DESPR)

Other Featured Speakers: Dr. Kyle Kampman and Dr. Charles Dackis,
University of Pennsylvania; Dr. Kathleen Brady, Medical University of South Carolina;
Dr. Nancy Petry, University of Connecticut School of Medicine; Dr. Walter Ling, UCLA School of Medicine

A full agenda and speaker list of the ASAM meeting can be found at

The National Institute on Drug Abuse is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug abuse and addiction. The Institute carries out a large variety of programs to ensure the rapid dissemination of research information and its implementation in policy and practice. Fact sheets on the health effects of drugs of abuse and information on NIDA research and other activities can be found on the NIDA home page at

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit

NIH…Turning Discovery Into Health®